High frequencies of elevated alkaline phosphatase activity and rickets exist in extremely low birth weight infants despite current nutritional support by Mitchell, Shannon M et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Pediatrics
Open Access Research article
High frequencies of elevated alkaline phosphatase activity and 
rickets exist in extremely low birth weight infants despite current 
nutritional support
Shannon M Mitchell1, Stefanie P Rogers1, Penni D Hicks2, 
Keli M Hawthorne2, Bruce R Parker3 and Steven A Abrams*1
Address: 1Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA, 2USDA/ARS Children's 
Nutrition Research Center, Houston, Texas, USA and 3Department of Radiology, Baylor College of Medicine and Texas Children's Hospital, 
Houston, Texas, USA
Email: Shannon M Mitchell - ShannonMitch@gmail.com; Stefanie P Rogers - Stefanie_Rogers@hotmail.com; 
Penni D Hicks - pennih@bcm.edu; Keli M Hawthorne - kelih@bcm.edu; Bruce R Parker - brucep@bcm.edu; 
Steven A Abrams* - sabrams@bcm.edu
* Corresponding author    
Abstract
Background: Osteopenia and rickets are common among extremely low birth weight infants (ELBW,
<1000 g birth weight) despite current practices of vitamin and mineral supplementation. Few data are
available evaluating the usual course of markers of mineral status in this population. Our objectives in this
study were to determine the relationship between birth weight (BW) and peak serum alkaline phosphatase
activity (P-APA) in ELBW infants and evaluate our experience with the diagnosis of rickets in these infants.
Methods: We evaluated all ELBW infants admitted to Texas Children's Hospital NICU in 2006 and 2007.
Of 211 admissions, we excluded 98 patients who were admitted at >30 days of age or did not survive/stay
for >6 weeks. Bone radiographs obtained in 32 infants were reviewed by a radiologist masked to
laboratory values.
Results: In this cohort of 113 infants, P-APA was found to have a significant inverse relationship with BW,
gestational age and serum phosphorus. In paired comparisons, P-APA of infants <600 g (957 ± 346 IU/L,
n = 20) and infants 600–800 g (808 ± 323 IU/L, n = 43) were both significantly higher than P-APA of infants
800–1000 g (615 ± 252 IU/L, n = 50), p < 0.01. Thirty-two patients had radiographic evaluation for
evidence of rickets, based on P-APA greater than 800 IU/L, parenteral nutrition greater than 3 to 4 weeks,
or clinical suspicion. Of these, 18 showed radiologic rickets and 14 showed osteopenia without rickets.
Infants with BW <600 g were more likely to have radiologic rickets (10/20 infants) compared to those with
BW 600–800 g (6/43 infants) and BW 800–1000 g (2/50 infants), p < 0.01 for each. P-APA was not
significantly higher in infants with radiologic rickets (1078 ± 356 IU/L) compared to those without
radiologic evidence of rickets (943 ± 346, p = 0.18).
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Conclusion: Elevation of P-APA >600 IU/L was very common in ELBW infants. BW was significantly
inversely related to both P-APA and radiologic rickets. No single value of P-APA was related to radiological
findings of rickets. Given the very high risk of osteopenia and rickets among ELBW infants, we recommend
consideration of early screening and early mineral supplementation, especially among infants <600 g BW.
Background
Metabolic bone disease is a common problem encoun-
tered in premature infants. This entity, also known as oste-
openia of prematurity, often leads to morbidity in the
form of fractures, which have been described in 30% of
infants <1500 g birth weight (BW) [1]. Metabolic bone
disease may also worsen respiratory problems in these
infants [2]. In its most severe form, rickets may be present,
not unlike that seen in older children. Evidence suggests
that metabolic bone disease may be associated with
decreased linear growth potential even after radiographic
and biochemical evidence of disease is corrected [3,4].
Metabolic bone disease is characterized by decreased bone
mineral density which occurs primarily as the result of
decreased mineral stores in preterm infants which may be
exacerbated by increased mineral demands in the neona-
tal period. Calcium (Ca) and phosphorus (P) are maxi-
mally acquired by the fetus during the third trimester of
pregnancy, so premature infants are born with signifi-
cantly lower mineral stores compared to term infants [5].
Additionally, supplementation of Ca and P in premature
infants at the levels needed to match the transplacental
accretion in the third trimester has proved challenging,
especially in patients who do not tolerate feeds and
require prolonged total parenteral nutrition (TPN) [6].
Use of medications such as corticosteroids, methylxan-
thines, and diuretics also appear to contribute to the
development of metabolic bone disease in preterm
infants [5].
Serum alkaline phosphatase activity (APA), serum P, and
serum Ca have traditionally been used to screen for meta-
bolic bone disease in preterm infants. Elevated APA and
decreased serum P have been shown to correlate with
increased risk of osteopenia and rickets in premature
infants [7,8]. Koo et al reported correlations between the
presence of skeletal demineralization and decreased birth
weight, decreased gestational age, decreased enteral feeds,
and elevated serum alkaline phosphatase activity levels in
infants <1500 g birth weight [9]. However, the usefulness
of APA and serum P as screening tools has been chal-
lenged [10]. There are currently no standard recommen-
dations for screening of metabolic bone disease and
rickets in preterm infants [11] nor are data available
describing the usual values of APA or serum P in extremely
low birth weight infants (ELBW, <1000 g BW).
In this study, we sought to determine usual peak serum
alkaline phosphatase activity (P-APA) in ELBW infants
and determine the frequency at which rickets is diagnosed
in these infants.
Methods
Using an existing database of neonatal intensive care unit
(NICU) admissions, we identified all ELBW patients
admitted to the Level 3 NICU at Texas Children's Hospital
from January 2006 through December 2007. Their medi-
cal records were reviewed and data collected with
approval from the Institution Review Board for Baylor
College of Medicine and Affiliated Institutions. The fol-
lowing data were initially obtained: gestational age (GA),
age at admission, and age at time of discharge or death.
Infants excluded from further analysis were admitted to
Texas Children's Hospital at age >30 days, were trans-
ferred to another institution prior to staying six weeks, or
died prior to staying six weeks in the NICU.
For the remaining patients in the study, the following lab-
oratory values were obtained: P-APA, serum Ca and serum
P at the time of P-APA, and maximum conjugated
bilirubin.
During this period, it was policy in our hospital to meas-
ure serum P and APA in all ELBW infants weekly until the
infants were receiving full enteral feeds and had shown a
clear pattern that the APA was no longer rising. Recom-
mended practice in our hospital at that time was that a
wrist or knee radiograph be obtained in infants who had
a persistently high APA (usually >800 IU/L for two meas-
urements taken at least one week apart) or had long-term
inadequate mineral intake. Long term inadequate mineral
intake was defined as intake below 150 mg/kg/day of cal-
cium or 75 mg/kg/day of phosphorous for at least 3
weeks. Inadequate mineral intake was most commonly
seen in infants on long term TPN (>3–4 weeks). Infants
with APA <800 IU/L receiving prolonged TPN (>3–4
weeks) or who were clinically suspected to have rickets
also received radiographs. All patients' radiographic
records were reviewed, and patients who had been evalu-
ated radiographically for the presence of rickets were iden-
tified. Presence or absence of the diagnoses cholestasis
(defined as conjugated bilirubin >2 mg/dL), bronchopul-
monary dysplasia, necrotizing enterocolitis, and gastroin-
testinal perforation were determined and recorded.BMC Pediatrics 2009, 9:47 http://www.biomedcentral.com/1471-2431/9/47
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All radiographs of these patients which were performed
for the purpose of evaluating for the presence of osteope-
nia and rickets were reviewed by an individual pediatric
radiologist who was masked to the laboratory values asso-
ciated with these patients. Radiographs obtained for these
evaluations included images of the wrist(s) and/or
knee(s). Patients were classified as normal, as having oste-
openia (evidence of low mineral density of the bones), or
as having rickets (loss of the zone of provisional calcifica-
tion or metaphyseal cupping and/or fraying).
SPSS (Version 16, Chicago, IL, 2007) was used to analyze
the data. General linear modeling was used to make group
comparisons. Data are presented as the Mean ± Standard
Deviation.
Results
A total of 211 infants were admitted to Texas Children's
Hospital NICU with a BW <1000 g between January 2006
and December 2007. Of these, 39 patients were excluded
from the study because they were admitted after 30 days
of age. An additional 59 patients were excluded from the
study because they either died before age six weeks or were
discharged before hospital length of stay reached six
weeks. The remaining cohort of 113 infants was the pop-
ulation for which all additional data were obtained and
analyzed.
In the cohort of 113 infants, the mean BW was 768 ± 153
g, and mean GA was 26 ± 2 weeks. Mean P-APA was 749
± 326 IU/L. P-APA was found to have significant inverse
relationships with BW, GA, and serum P (Table 1). Serum
P had a direct correlation with BW (r = 0.36, p < 0.001).
In paired comparisons, P-APA of infants <600 g (957 ±
346 IU/L, n = 20) and infants 600–800 g (808 ± 323 IU/
L, n = 43) were both significantly higher than P-APA of
infants 800–1000 g (615 ± 252 IU/L, n = 50), p < 0.01
(Figure 1). The difference in P-APA between infants <600
g and infants 600–800 g was marginally significant (p =
0.07).
Thirty-two patients in our study population of 113 had
radiographic evaluation for osteopenia or rickets. Only
infants who had APA >800 IU/L on two occasions at least
one week apart, who received TPN for >3–4 weeks, or who
were clinically suspected to have osteopenia or rickets
received these particular radiographic evaluations. Of the
32 studies, 18 showed radiologic rickets. The other 14
radiographic studies showed osteopenia without rickets.
Infants with BW <600 g were significantly more likely to
have radiologic rickets (10/20 infants) compared to those
with BW 600–800 g (6/43 infants) and BW 800–1000 g
(2/50 infants). Table 2 shows the number of infants eval-
uated for rickets and the number diagnosed with radio-
logic rickets for different ranges of P-APA.
P-APA was significantly higher in infants with radiologic
diagnosis of rickets (1078 ± 357 IU/L) compared to
infants who were not evaluated for rickets with radio-
graphs (642 ± 245 IU/L, p < 0.001), but not those whose
radiographs did not demonstrate rickets (943 ± 346 IU/L,
p = 0.18). However, four infants with rickets did have P-
APA <800 IU/L. Seventeen infants with P-APA >800 IU/L
did not have radiographic evaluation for rickets. Mean
serum P was slightly lower in infants with rickets (5.1 ±
0.2 mg/dL) compared to infants who were not evaluated
for rickets (5.6 ± 0.1 mg/dL, p = 0.03), but not those
whose radiographs did not demonstrate rickets (5.3 ± 0.3
mg/dL, p = 0.52). There was no close correlation between
serum Ca and the diagnosis of rickets. The BW, P-APA,
and serum P for the 32 patients in which radiographic
rickets evaluation were obtained are shown in Table 3.
The average maximum conjugated bilirubin of the 113
infants was 3.7 ± 5.3 mg/dL. Fifty-five of the infants had
the diagnosis of cholestasis based on maximum conju-
Table 1: Correlations between peak alkaline phosphatase activity 
(P-APA) and birth weight, gestational age, and serum 
phosphorus.
Independent Variable Dependent Variable r-value p-value
Birth Weight P-APA -0.36 < 0.001
Gestational Age P-APA -0.28 0.003
Serum Phosphorus P-APA -0.28 0.003
Average peak alkaline phosphatase according to birth weight Figure 1
Average peak alkaline phosphatase according to 
birth weight.BMC Pediatrics 2009, 9:47 http://www.biomedcentral.com/1471-2431/9/47
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gated bilirubin >2.0 mg/dL. Eighty-seven of the infants
had a diagnosis of bronchopulmonary dysplasia. Twenty-
five of the infants had a diagnosis of necrotizing entero-
colitis, and 12 had a diagnosis of gastrointestinal perfora-
tion. Diagnoses of cholestasis, bronchopulmonary
dysplasia, necrotizing enterocolitis, and gastrointestinal
perforation were not significantly associated with the radi-
ographic diagnosis of rickets. However, P-APA was higher
in the 55 patients with cholestasis (867 ± 311 IU/L) com-
pared to the 58 patients without cholestasis (636 ± 302
IU/L, p < 0.001). A total of 28/55 subjects with cholestasis
(51%) had a P-APA > 800 IU/L of which 13 were > 1000
IU/L. Only 12/58 subjects without cholestasis (21%) had
a P-APA > 800 IU/L of which 6 were > 1000 IU/L.
Discussion
We found that, despite modern nutritional management,
rickets is a common clinical problem in a large NICU set-
ting. A total of 18 of 113 patients <1000 g BW were diag-
nosed with radiographic rickets over a 24 month time
period in our NICU. Mean P-APA exceeded 600 IU/L in all
subgroups and exceeded 950 IU/L in those <600 g BW.
Nonetheless, among those infants who received a radio-
graph to evaluate rickets, there was no significant differ-
ence in P-APA in those in whom rickets was diagnosed
compared to those who had osteopenia without rickets.
Although rickets is not a reportable condition in any age
group in the United States, it is likely that the number of
preterm infants with rickets exceeds the number of older
children with rickets. Regardless, it remains clear that rick-
ets is an important clinical event in the NICU population
with substantial morbidity [1]. In addition, evidence sug-
gests that metabolic bone disease may contribute to
decreased linear growth long after biochemical and radio-
graphic evidence of metabolic bone disease has been cor-
rected [3,4].
The diagnosis of rickets generally remains dependent on
clinical suspicion and on biochemical P-APA data with a
radiograph verifying the findings. Physical examination
may reveal signs of osteopenia or rickets, including path-
ologic fractures or bony prominences at the costochon-
dral junctions [5]. Dual energy X-ray absorptiometry is a
sensitive indicator of decreased bone mineral density
which has been studied in preterm infants, but its use in
the screening of osteopenia has been limited [5]. Standard
radiographs currently used to evaluate infants for meta-
bolic bone disease have limited utility because they show
evidence of osteopenia only after bone density is signifi-
cantly impaired [12].
We cannot identify the sensitivity as not all infants
received radiographic evaluation for rickets, including
seventeen infants with P-APA >800 IU/L, and therefore we
cannot determine the true incidence of radiographic rick-
ets in this population. However, we did determine that
radiographic rickets developed in at least 50% of infants
<600 g BW, at least 14% of infants 600–800 g BW, and at
least 4% of infants 800–1000 g BW.
The reason for a high rate of rickets in infants <1000 g BW
and especially those <600 g BW is unknown. In the United
States, preterm formulas, fortified human milk and TPN
delivered via central access provide about 80–100 mg/kg/
d of retained Ca and approximately half that amount of
retained P when appropriate nutrition is successfully pro-
vided. However, clinical concerns such as lack of central
access, fluid restriction, and/or feeding intolerance may
limit nutrient delivery, leading to suboptimal delivery of
Ca and P. The in utero accretion rate for Ca peaks in the
early 3rd trimester at about 100–120 mg/kg/d [13]. The
large differences in P-APA and percentage of infants diag-
nosed with rickets within a narrow range of birth weights
may be caused by other factors in addition to differences
between in utero Ca retention among these infants. It is
possible that there is a unique and extremely elevated
short term demand for minerals in these smallest infants
that is not met by any of the usual nutrient delivery sys-
tems. It is also possible that elevated APA levels in these
infants are not specific for the presence of rickets, and
other factors including cholestasis may complicate the
interpretation of elevated APA. Extremely high mineral
demands in ELBW infants have not been documented in
the literature, except for a single case report. This case
report describes an infant with persistent radiographic
Table 2: Patients evaluated for and diagnosed with rickets grouped according to peak alkaline phosphatase activity (P-APA).
P-APA (IU/L) Number of Patients Number Evaluated for Rickets Number Diagnosed with Rickets
<600 42 2 1
600–800 29 6 3
800–1000 23 10 4
>1000 19 14 10BMC Pediatrics 2009, 9:47 http://www.biomedcentral.com/1471-2431/9/47
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Table 3: Birth weight, peak alkaline phosphatase activity (P-APA), and serum phosphorus of the 32 individuals radiographically 
evaluated for rickets.
Birth Weight (g) P-APA (IU/L) Serum Phosphorus (mg/dL) Rickets diagnosed
437 801 5.7 Yes
460 1329 5.2 Yes
480 1013 7.4 Yes
492 474 5.3 Yes
503 799 5.7 Yes
540 760 4.9 Yes
550 1462 5.5 Yes
550 1426 3.7 No
554 1873 - Yes
580 1334 4.6 Yes
590 839 4.3 No
590 908 4.9 Yes
611 836 4.6 No
660 1141 3.7 Yes
660 1902 6.7 No
660 1029 5.8 No
695 743 4.4 No
697 859 4 Yes
708 933 4.3 No
720 489 6.7 No
720 712 5.2 No
735 1001 6 No
740 834 6.6 No
740 1101 4.4 Yes
760 728 5.1 No
793 1083 5.3 Yes
795 863 5 YesBMC Pediatrics 2009, 9:47 http://www.biomedcentral.com/1471-2431/9/47
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rickets and elevated APA. After receiving daily calcium and
phosphorus doses of 600 mg/kg and 500 mg/kg, respec-
tively, APA levels improved [14].
Although overall growth rates are not excessive in ELBW
infants, whether on TPN or enteral feeds, we suggest that
very high APA and rickets may be caused by rapid bone
growth in these infants which exceeds bone growth in
utero. This rapid bone growth has not been documented in
the literature. We did not document the feeding or TPN
course of the infants in the study. However, acute gas-
trointestinal events including necrotizing enterocolitis
and gastrointestinal perforation were not increased in the
infants with rickets. Such events generally require reduc-
tion in enteral feeds in conjunction with increased TPN
delivery.
Clinically, the total APA is often used as a marker for
nutritional intervention. APA was first suggested as a
screening tool for neonatal rickets based on a study
including 30 premature infants [8]. Backström et al dem-
onstrated that total APA >900 IU/L at three months cor-
rected GA predicted radiographic osteopenia with 88%
sensitivity and 71% specificity, with concomitant
decreased serum P levels improving sensitivity [15]. Other
studies have shown that radiographic osteopenia and rick-
ets are correlated with APA [16,17]. P-APA has been
shown to precede radiographic changes by 2–4 weeks
[16]. Elevated APA is associated with hypophosphatemia
[17] and decreased bone strength [18] in preterm infants.
In addition, elevated P-APA has been shown to correlate
with reduced neonatal growth and reduced length at 18
months [17]. However, results of a study by Faerk et al
challenged the utility of APA and serum P in predicting
bone mineralization in premature infants. This study
demonstrated no association between bone mineral con-
tent and any of the following: P-APA, mean serum APA,
and mean serum P [10].
Our data indicate that elevated APA level should not be
the only factor prompting radiographic evaluation for
rickets, as rickets occurred in infants even with APA <600
IU/L. Our study supports the existing data that P defi-
ciency is important in the development of metabolic bone
disease [7], but serum P is also not an adequate diagnostic
tool. BW alone may be a more sensitive indicator of rick-
ets than biochemical markers in patients with BW <600 g.
We propose the following guidelines for clinicians evalu-
ating ELBW infants for rickets. In general, we recommend
that a radiograph of the wrist and/or knee to evaluate for
rickets be obtained in premature infants when multiple
measurements of APA are >800 IU/L (two levels measured
at least one week apart), and/or the APA approaches or
exceeds 1000 IU/L. A prolonged need for TPN (>3–4
weeks), or suspicion of fracture, or abnormal bone find-
ings on an incidental radiograph should also trigger a
radiographic evaluation for rickets. An additional policy
of screening all infants <600 g BW with a radiograph of
the wrist or knee when on full feeds or at about six weeks
795 1718 5.3 Yes
858 781 3.7 Yes
869 816 5.4 No
915 915 5.3 No
995 1107 5.6 Yes
Table 3: Birth weight, peak alkaline phosphatase activity (P-APA), and serum phosphorus of the 32 individuals radiographically 
evaluated for rickets. (Continued)
Flow diagram to guide radiographic evaluation for rickets Figure 2
Flow diagram to guide radiographic evaluation for 
rickets.
Alkaline Phosphatase Activity  
(measured weekly or bi-weekly) 
> 600g 
Obtain radiograph of 
wrist and/or knee to 
evaluate for rickets. 
Clinical suspicion of rickets 
(incidental findings on unrelated 
radiograph, fracture, parenteral 
nutrition for >3-4 weeks, APA 
>800 IU/L on two measurements 
taken at least one week apart) 
No clinical 
suspicion of 
rickets 
Any Value 
>1000 IU/L 
< 1000 IU/L 
Obtain radiograph of 
wrist and/or knee to 
evaluate for rickets at 
age six weeks or at 
time of full feeds. 
Obtain radiograph of 
wrist and/or knee to 
evaluate for rickets. 
< 600g 
Continue to monitor 
alkaline phosphatase 
activity until <500 IU/L. 
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WeightPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Pediatrics 2009, 9:47 http://www.biomedcentral.com/1471-2431/9/47
Page 7 of 7
(page number not for citation purposes)
of age would also be reasonable. Infants >600 g BW with
APA less than about 1000 IU/L and no clinical evidence of
rickets may be followed with weekly or bi-weekly APA
measurements (until levels are <500 IU/L) without addi-
tional evaluation or intervention, especially if they are
receiving adequate mineral intake (Figure 2). We recom-
mend that early nutritional intervention in infants with
BW <600 g or APA >800 IU/L may be indicated to prevent
a further rise in APA and the development of rickets.
Conclusion
Elevation of APA >600 IU/L was very common in ELBW
infants. BW was significantly inversely related to both P-
APA and rickets. No single value of APA was related to
radiological findings of rickets. Given the very high risk of
osteopenia and rickets among ELBW infants, we recom-
mend consideration of early screening and early mineral
supplementation, especially among infants <600 g BW or
APA >800 IU/L.
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